PH

Paul J. Hergenrother

Founder, Director & CSO at Vanquish Oncology

The procaspase 3 activation technology was invented in Professor Hergenrother’s laboratory, and he serves as the Company’s Chief Scientific Officer and as a Director. Paul provides key scientific and technical expertise to the Company’s development efforts and leads all research activities. Paul is the Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry and Professor of Chemistry at the University of Illinois, Urbana-Champaign.

Peers

View in org chart

Timeline

  • Founder, Director & CSO

    Current role